Breakthroughs in basic and clinical research
in chronic respiratory disease

Parma, Auditorium Paganini
26th May 2017

Scientific Referee: Prof. Dario Olivieri 


Discussing with renowned experts about the new achievements in the pathophysiology and therapy of diseases that represent the daily engagement of each participant is undoubtedly one of the most appreciated asset of Respiration Day.
This year, we will be able to increase the value of what we take home from this event. In fact, Sir Richard Peto will give us a lecture on pulmonary and extrapulmonary effects of smoking. Then, the program will foresee an exciting excursus of the novel anti-inflammatory agents in development in asthma and COPD led by Prof. Barnes. The following session will focus on a hot topic: the role of small airways in asthma and its diagnosis with interesting new evidence.
Early intervention and multiple therapies in chronic diseases will be the fil rouge of the following three lectures that will give us an informed look at the modern management of three increasingly prevalent diseases: diabetes, asthma, and COPD.

The final morning session, will illustrate the state of the art of the research effort to achieve a valuable change in the clinical course of COPD.

The programme will continue in the afternoon with a session specifically devoted to immunotherapy in chronic diseases based upon the research in oncology, and a lecture focusing on the major recent breakthroughs in asthma that will give voice to both basic and clinical science.

Finally, the conference will offer a session centred around targeted therapy in asthma with a focus on monoclonal antibodies and personalised approaches to diagnosis and treatment.